232 related articles for article (PubMed ID: 12947002)
1. Identification of novel CTL epitopes of CMV-pp65 presented by a variety of HLA alleles.
Kondo E; Akatsuka Y; Kuzushima K; Tsujimura K; Asakura S; Tajima K; Kagami Y; Kodera Y; Tanimoto M; Morishima Y; Takahashi T
Blood; 2004 Jan; 103(2):630-8. PubMed ID: 12947002
[TBL] [Abstract][Full Text] [Related]
2. Efficient identification of HLA-A*2402-restricted cytomegalovirus-specific CD8(+) T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay.
Kuzushima K; Hayashi N; Kimura H; Tsurumi T
Blood; 2001 Sep; 98(6):1872-81. PubMed ID: 11535524
[TBL] [Abstract][Full Text] [Related]
3. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.
Wills MR; Carmichael AJ; Mynard K; Jin X; Weekes MP; Plachter B; Sissons JG
J Virol; 1996 Nov; 70(11):7569-79. PubMed ID: 8892876
[TBL] [Abstract][Full Text] [Related]
4. Identification of three HLA-A*0201-restricted cytotoxic T cell epitopes in the cytomegalovirus protein pp65 that are conserved between eight strains of the virus.
Solache A; Morgan CL; Dodi AI; Morte C; Scott I; Baboonian C; Zal B; Goldman J; Grundy JE; Madrigal JA
J Immunol; 1999 Nov; 163(10):5512-8. PubMed ID: 10553078
[TBL] [Abstract][Full Text] [Related]
5. Identification of the HLA-A24 peptide epitope within cytomegalovirus protein pp65 recognized by CMV-specific cytotoxic T lymphocytes.
Masuoka M; Yoshimuta T; Hamada M; Okamoto M; Fumimori T; Honda J; Oizumi K; Itoh K
Viral Immunol; 2001; 14(4):369-77. PubMed ID: 11792066
[TBL] [Abstract][Full Text] [Related]
6. Identification of HLA-A24-restricted CTL epitope encoded by the matrix protein pp65 of human cytomegalovirus.
Akiyama Y; Maruyama K; Mochizuki T; Sasaki K; Takaue Y; Yamaguchi K
Immunol Lett; 2002 Aug; 83(1):21-30. PubMed ID: 12057851
[TBL] [Abstract][Full Text] [Related]
7. Efficient generation of antigen-specific cytotoxic T cells using retrovirally transduced CD40-activated B cells.
Kondo E; Topp MS; Kiem HP; Obata Y; Morishima Y; Kuzushima K; Tanimoto M; Harada M; Takahashi T; Akatsuka Y
J Immunol; 2002 Aug; 169(4):2164-71. PubMed ID: 12165546
[TBL] [Abstract][Full Text] [Related]
8. HLA tetramers and anti-CMV immune responses: from epitope to immunotherapy.
Chen FE; Aubert G; Travers P; Dodi IA; Madrigal JA
Cytotherapy; 2002; 4(1):41-8. PubMed ID: 11953040
[TBL] [Abstract][Full Text] [Related]
9. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C
Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452
[TBL] [Abstract][Full Text] [Related]
10. Rapid monitoring of immune reconstitution after allogeneic stem cell transplantation--a comparison of different assays for the detection of cytomegalovirus-specific T cells.
Abu-Khader A; Krause S
Eur J Haematol; 2013 Dec; 91(6):534-45. PubMed ID: 23952609
[TBL] [Abstract][Full Text] [Related]
11. Infrequent occurrence of natural mutations in the pp65(495-503) epitope sequence presented by the HLA A*0201 allele among human cytomegalovirus isolates.
Zaia JA; Gallez-Hawkins G; Li X; Yao ZQ; Lomeli N; Molinder K; La Rosa C; Diamond DJ
J Virol; 2001 Mar; 75(5):2472-4. PubMed ID: 11160752
[TBL] [Abstract][Full Text] [Related]
12. Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes.
McLaughlin-Taylor E; Pande H; Forman SJ; Tanamachi B; Li CR; Zaia JA; Greenberg PD; Riddell SR
J Med Virol; 1994 May; 43(1):103-10. PubMed ID: 8083644
[TBL] [Abstract][Full Text] [Related]
13. Identification of T cell epitopes by the use of rapidly generated mRNA fragments.
Britten CM; Meyer RG; Graf C; Huber C; Wölfel T
J Immunol Methods; 2005 Apr; 299(1-2):165-75. PubMed ID: 15914199
[TBL] [Abstract][Full Text] [Related]
14. Identification of immune dominant cytomegalovirus epitopes using quantitative real-time polymerase chain reactions to measure interferon-gamma production by peptide-stimulated peripheral blood mononuclear cells.
Provenzano M; Mocellin S; Bettinotti M; Preuss J; Monsurrò V; Marincola FM; Stroncek D
J Immunother; 2002; 25(4):342-51. PubMed ID: 12142557
[TBL] [Abstract][Full Text] [Related]
15. Generation of cytomegalovirus-specific human T-lymphocyte clones by using autologous B-lymphoblastoid cells with stable expression of pp65 or IE1 proteins: a tool to study the fine specificity of the antiviral response.
Retière C; Prod'homme V; Imbert-Marcille BM; Bonneville M; Vié H; Hallet MM
J Virol; 2000 May; 74(9):3948-52. PubMed ID: 10756006
[TBL] [Abstract][Full Text] [Related]
16. Relative dominance of HLA-B*07 restricted CD8+ T-lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A*02 and HLA-B*07 alleles.
Lacey SF; Villacres MC; La Rosa C; Wang Z; Longmate J; Martinez J; Brewer JC; Mekhoubad S; Maas R; Leedom JM; Forman SJ; Zaia JA; Diamond DJ
Hum Immunol; 2003 Apr; 64(4):440-52. PubMed ID: 12651070
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cells.
Keever-Taylor CA; Margolis D; Konings S; Sandford GR; Nicolette CA; Lawendowski C; Burns WH
Biol Blood Marrow Transplant; 2001; 7(5):247-56. PubMed ID: 11400946
[TBL] [Abstract][Full Text] [Related]
18. The matrix protein pp65(341-350): a peptide that induces ex vivo stimulation and in vitro expansion of CMV-specific CD8+ T cells in subjects bearing either HLA-A*2402 or A*0101 allele.
Provenzano M; Lim JB; Mocellin S; Monsurro V; Bettinotti M; Marincola FM; Stroncek DF
Transfusion; 2003 Nov; 43(11):1567-74. PubMed ID: 14617317
[TBL] [Abstract][Full Text] [Related]
19. A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects.
Berencsi K; Gyulai Z; Gönczöl E; Pincus S; Cox WI; Michelson S; Kari L; Meric C; Cadoz M; Zahradnik J; Starr S; Plotkin S
J Infect Dis; 2001 Apr; 183(8):1171-9. PubMed ID: 11262198
[TBL] [Abstract][Full Text] [Related]
20. Generation of CMV-specific T lymphocytes using protein-spanning pools of pp65-derived overlapping pentadecapeptides for adoptive immunotherapy.
Trivedi D; Williams RY; O'Reilly RJ; Koehne G
Blood; 2005 Apr; 105(7):2793-801. PubMed ID: 15514011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]